Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04067115
Title SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients (U01CA236220)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration
Indications

Ewing sarcoma

Therapies

Irinotecan + Trabectedin

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.